Exicure (XCUR) Other Non Operating Income (2016 - 2025)
Exicure (XCUR) reported Other Non Operating Income of -$255000.0 for Q4 2025, down 2218.18% quarter-over-quarter from -$11000.0 in Q3 2025.
Exicure (XCUR) Other Non Operating Income (2016 - 2025) Analysis & Trends
Exicure has reported Other Non Operating Income for 10 years, with the latest figure at -$255000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non Operating Income changed N/A year-over-year to -$255000.0; the trailing twelve-month figure through Dec 2025 stood at -$301000.0 (down 114.12% YoY), and the FY2025 full-year result was -$275000.0, down 112.87% from the prior year.
- Other Non Operating Income for Q4 2025 stood at -$255000.0, down from -$11000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $1.5 million in Q3 2024, with the low at -$255000.0 in Q4 2025.
- Historically, Other Non Operating Income has averaged $118466.7 across 5 years, with a median of -$5000.0 in 2021.
- Annual changes were most pronounced in 2023 — Other Non Operating Income plunged 3650.0% — and 2024, when it surged 3309.09%.
- Exicure's Other Non Operating Income stood at -$4000.0 in 2021, then slumped by 300.0% to -$16000.0 in 2022, then surged by 375.0% to $44000.0 in 2023, then surged by 3309.09% to $1.5 million in 2024, then plunged by 117.0% to -$255000.0 in 2025.
- The last three Other Non Operating Income figures came in at -$255000.0 (Q4 2025), -$11000.0 (Q3 2025), and -$9000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -255,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Jun 30, 2025 | -9,000.00 |
| Mar 31, 2025 | -26,000.00 |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 631,000.00 |
| Sep 30, 2023 | 44,000.00 |
| Jun 30, 2023 | -150,000.00 |
| Mar 31, 2023 | 104,000.00 |
| Dec 31, 2022 | -16,000.00 |
| Jun 30, 2022 | -4,000.00 |
| Mar 31, 2022 | -20,000.00 |
| Dec 31, 2021 | -4,000.00 |
| Sep 30, 2021 | -5,000.00 |
| Jun 30, 2021 | -2,000.00 |
| Dec 31, 2020 | 51,000.00 |
| Sep 30, 2020 | 118,000.00 |
| Jun 30, 2020 | -192,000.00 |
| Mar 31, 2020 | 345,000.00 |
| Dec 31, 2019 | 22,000.00 |